期刊
CELLS
卷 9, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/cells9051082
关键词
lysosomes; lysosomotropic drugs; drug sequestration; membrane intercalation; molecular dynamics
类别
资金
- FCT [SFRH/BD/140886/2018, CEECIND/02300/2017, UID/MULTI/04046/2019]
- COST (European Cooperation in Science and Technology) [CA17104]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/140886/2018] Funding Source: FCT
Lipophilic weak base therapeutic agents, termed lysosomotropic drugs (LDs), undergo marked sequestration and concentration within lysosomes, hence altering lysosomal functions. This lysosomal drug entrapment has been described as luminal drug compartmentalization. Consistent with our recent finding that LDs inflict a pH-dependent membrane fluidization, we herein demonstrate that LDs undergo intercalation and concentration within lysosomal membranes. The latter was revealed experimentally and computationally by (a) confocal microscopy of fluorescent compounds and drugs within lysosomal membranes, and (b) molecular dynamics modeling of the pH-dependent membrane insertion and accumulation of an assortment of LDs, including anticancer drugs. Based on the multiple functions of the lysosome as a central nutrient sensory hub and a degradation center, we discuss the molecular mechanisms underlying the alteration of morphology and impairment of lysosomal functions as consequences of LDs' intercalation into lysosomes. Our findings bear important implications for drug design, drug induced lysosomal damage, diseases and pertaining therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据